These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37978877)

  • 1. Midterm Results of Drug-Coated Balloon and Bare Metal Stent in the Treatment of TASCII C/D Femoropopliteal Artery Occlusive Disease: A Retrospective Multicenter Study.
    Xiao L; Gu S; Chen Y; Zhang X; Wang Y; Dai X
    J Endovasc Ther; 2023 Nov; ():15266028231209932. PubMed ID: 37978877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mid-term Efficacy and Safety of Drug-coated Balloon versus Nitinol Bare Metal Stent for Primary Lesions in Femoropopliteal Artery Disease.
    Ma H; Zhang X; Li J; Li Q; Li W; Jiao Y; Jiang J; He C; He Z; Li W; Zhang T; Zhang X
    Ann Vasc Surg; 2022 Apr; 81():316-323. PubMed ID: 34762999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial Disease.
    Shishehbor MH; Scheinert D; Jain A; Brodmann M; Tepe G; Ando K; Krishnan P; Iida O; Laird JR; Schneider PA; Rocha-Singh KJ; Zeller T
    J Am Coll Cardiol; 2023 Jan; 81(3):237-249. PubMed ID: 36332764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-coated balloons versus bare metal stent for treatment of femoropopliteal lesions:36 month follow-up results of single center].
    Fang J; Qu CJ; Zhang YB; Teng LQ; Li JL; Shen CY
    Zhonghua Wai Ke Za Zhi; 2021 Dec; 59(12):975-979. PubMed ID: 34839611
    [No Abstract]   [Full Text] [Related]  

  • 6. The Midterm Outcomes of Endovascular Therapy for Femoropopliteal Lesions via Drug-Coated Balloon, Directional Atherectomy and Bare Metal Stent Angioplasty.
    Lin Y; Quan J; Dong J; Cong L; Yang L
    Rev Cardiovasc Med; 2024 Sep; 25(9):331. PubMed ID: 39355603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Stented vs Nonstented Femoropopliteal Lesions Treated With Drug-Coated Balloon Angioplasty.
    Giannopoulos S; Strobel A; Rudofker E; Kovach C; Kokkosis AA; Armstrong EJ
    J Endovasc Ther; 2023 Apr; 30(2):194-203. PubMed ID: 35179065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and Comparative Analysis of the Initial Results of Standard Balloon Angioplasty Versus Drug-Coated Balloons Alone Versus in Association With Laser-Excimer Atherectomy in the Treatment of Femoropopliteal Artery In-Stent Restenosis (INTACT).
    Ducasse E; Sapoval M; Brunet J; Commeau P; Goueffic Y; Sabatier J; Steinmetz E; Lermusiaux P; Rosset E; Caradu C
    J Endovasc Ther; 2024 Apr; ():15266028241248333. PubMed ID: 38659343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety Differences between Domestic Paclitaxel Drug-Coated Balloons and Metal Bare Stents in the Treatment of ASO of Femoral-Popliteal Arteries Type IIA-C.
    Wei F; Huang F; Cui F
    Contrast Media Mol Imaging; 2022; 2022():6817838. PubMed ID: 35854777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study).
    García-Touchard A; Sabaté M; Gonzalo N; Peral V; Vaquerizo B; Ruiz-Salmerón R; García Del Blanco B; Jiménez-Mazuecos J; Molina E; Martínez-Romero P; Hernandez-García JM; Ruiz-Quevedo V; Urbano C; Fernández-Portales J; Rumoroso JR; Casanova-Sandoval J; Pinar E; Lopez-Pais J; Oteo JF; Alfonso F
    Cardiovasc Diagn Ther; 2023 Oct; 13(5):792-804. PubMed ID: 37941845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Coated Balloon versus Bare Nitinol Stent in Femoropopliteal Artery: 12 Months Outcome from a Single Center in China.
    Zhao H; Ma B; Chen J; Zheng L; Sun CR; Sun MS; Zhang JB; Fan XQ; Liu P; Ye ZD
    Ann Vasc Surg; 2021 Jul; 74():367-381. PubMed ID: 33556529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
    Rodoplu O; Oztas DM; Meric M; Beyaz MO; Ulukan MO; Yildiz CE; Unal O; Ugurlucan M
    Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mid-outcome among bare metal stent, atherectomy with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion.
    Yang L; Quan J; Dong J; Ding N; Han Y; Cong L; Lin Y; Liu J
    Sci Rep; 2024 Jan; 14(1):63. PubMed ID: 38167567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining the Passeo-18 Lux Drug-Coated Balloon and the Pulsar-18 Bare Metal Stent: 12- and 24-Month Outcomes of the BIOLUX 4EVER Investigator-Initiated Trial.
    Deloose K; Bosiers M; Peeters P; Verbist J; Maene L; Beelen R; Keirse K; Hendriks J; Lauwers P; Wauters J; Verschueren M
    J Endovasc Ther; 2020 Dec; 27(6):936-945. PubMed ID: 32873131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical efficacy of drug-coated balloon angioplasty for TASCII C/D femoropopliteal lesions in older patients with chronic limb-threatening ischemia: A retrospective study.
    Zhang F; Song HX; Zheng LH; An YB; Liu P
    Medicine (Baltimore); 2024 Aug; 103(33):e39331. PubMed ID: 39151525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stent Graft vs Drug-Coated Balloon in Endovascular Treatment of Complex Femoropopliteal Artery Lesions: A 2-Center Experience.
    Ye M; Ni Q; Zhu Y; Du Y; Wang Y; Guo X; Zhang L; Feng Z
    J Endovasc Ther; 2023 Sep; ():15266028231201097. PubMed ID: 37728023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Coated Balloon and Drug-Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease.
    Hanna J; Smolderen KG; Castro-Dominguez Y; Romain G; Lee M; Turner J; Mena-Hurtado C
    J Am Heart Assoc; 2023 Apr; 12(7):e028622. PubMed ID: 36974774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Single-Center Study on the Outcomes of Target Limb Revascularization in Femoropopliteal Lesions Treated With Drug Coated Balloons and Bare Metal Stents.
    Linehan V; Doyle M; Barrett B; Gullipalli R
    J Endovasc Ther; 2022 Dec; 29(6):948-955. PubMed ID: 34986705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midterm Results of Drug-Coated Balloon Alone or Combined with Rotarex Thrombectomy Device for Treatment of Subacute Femoropopliteal Artery Thrombotic Occlusion.
    Fan W; Lu S; Tan J; Cui X; Liang K; Zhu L; He Q; Yu B; Shi W
    Ann Vasc Surg; 2023 May; 92():240-248. PubMed ID: 36503024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.